GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Mentor Capital Inc (OTCPK:MNTR) » Definitions » Days Sales Outstanding

Mentor Capital (Mentor Capital) Days Sales Outstanding : 0.00 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Mentor Capital Days Sales Outstanding?

Mentor Capital's average Accounts Receivable for the three months ended in Dec. 2023 was $0.37 Mil. Mentor Capital's Revenue for the three months ended in Dec. 2023 was $-6.43 Mil.

The historical rank and industry rank for Mentor Capital's Days Sales Outstanding or its related term are showing as below:

During the past 11 years, Mentor Capital's highest Days Sales Outstanding was 3686.50. The lowest was 30.51. And the median was 47.16.

MNTR's Days Sales Outstanding is not ranked *
in the Capital Markets industry.
Industry Median: 65.17
* Ranked among companies with meaningful Days Sales Outstanding only.

Mentor Capital's Days Sales Outstanding stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

Mentor Capital Days Sales Outstanding Historical Data

The historical data trend for Mentor Capital's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mentor Capital Days Sales Outstanding Chart

Mentor Capital Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.50 38.95 36.86 3,686.50 -

Mentor Capital Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 15.25 29.75 29.19 -

Competitive Comparison of Mentor Capital's Days Sales Outstanding

For the Capital Markets subindustry, Mentor Capital's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mentor Capital's Days Sales Outstanding Distribution in the Capital Markets Industry

For the Capital Markets industry and Financial Services sector, Mentor Capital's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Mentor Capital's Days Sales Outstanding falls into.


Mentor Capital Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Mentor Capital's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.001 + 0.002) / 2 ) / 0*365
=0.0015 / 0*365
=N/A

Mentor Capital's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.73 + 0.002) / 2 ) / -6.433*365 / 4
=0.366 / -6.433*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mentor Capital  (OTCPK:MNTR) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Mentor Capital Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Mentor Capital's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Mentor Capital (Mentor Capital) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Mentor Capital Inc (OTCPK:MNTR) » Definitions » Days Sales Outstanding
Comparable Companies
MGHL NHMD NIHK BETSF MGTI CCTL LGHL VTXB SYSX MVCO MS GS SCHW ASX:MQG SHSE:600030 BSP:BPAC3 RJF TW LPLA SHSE:601066
Traded in Other Exchanges
N/A
Address
5964 Campus Court, Plano, TX, USA, 75093
Website
https://www.mentorcapital.com
Mentor Capital Inc acquires and provides liquidity for medical and social use cannabis companies. The company is operating an acquisition and investment business. It operates through two segments namely the historic cannabis and medical marijuana segment, and the Company's legacy investment in WCI, which works with business park owners, governmental centers, and apartment complexes to reduce their facility-related operating costs. The cannabis and medical marijuana segment include the operation of subsidiaries in the Cannabis and medical marijuana sector. Mentor's focus is medical and the company seeks to facilitate the application of cannabis to cancer wasting, calming seizures, and Parkinson's disease, reducing ocular pressures from glaucoma, and blunting chronic pain.
Executives
David G. Carlile director 10901 BULLRUSH DRIVE, VENICE FL 34293
Lori Stansfield officer: Chief Financial Officer 903 N. TOWNER STREET, SANTA ANA CA 92703
Chester Billingsley director, 10 percent owner, officer: Chief Executive Officer 5964 CAMPUS COURT, PLANO TX 75093
Stan Shaul director 2586 CLAYBOURNE COURT, NEWBURY PARK CA 91320
Robert Bernhard Meyer director 24446 CASWELL COURT, LAGUNA NIGUEL CA 92677
Earl Kornbrekke director 458 DEHARO LANE, FRIDAY HARBOR WA 98250
James Blazeck director 536 OVERLOOK DRIVE, PITTSBURG PA 15216